88IV - Public company info - Everest Medicines Limited

Input the stock code or the company name

Everest Medicines Limited, 01952.HK - Corporate Information
Substantial Shareholders	C-Bridge Investment Everest Limited(17.05%) C-Bridge IV Investment Two Limited(13.08%) Everest Management Holding Co., Ltd(8.19%) C-Bridge IV Investment Nine Limited(5.21%)
Directors	Wei Fu(Chairman and Executive Director) Kerry Levan Blanchard(Chief Executive Officer and Executive Director) Ian Ying Woo(President and Executive Director) Xiaofan Zhang(Executive Director) Yubo Gong(Non-Executive Director) Lan Kang(Non-Executive Director) Bo Tan(Independent Non-Executive Director) Yifan Li(Independent Non-Executive Director) Shidong Jiang(Independent Non-Executive Director)
Company Secretary	Yin Yin Yee Wa Lau
Principal Bankers	Silicon Valley Bank
Solicitors	Skadden, Arps, Slate, Meagher & Flom and affiliates Zhong Lun Law Firm Maples and Calder (Hong Kon
Auditors	PricewaterhouseCoopers
Registered Office	Level 54, Hopewell Centre 183 Queen’s Road East Hong Kong
Share Registrars	Computershare Hong Kong Investor Services Limited
Share Registrars Tel No	(852) 2862-8600
Internet Address	http://www.everestmedicines.com/
Email Address	IR@everestmedicines.com
Tel No	-
Fax No	-

Public company info - Everest Medicines Limited , 01952.HK